Forticell Bioscience, Incorporation - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Forticell Bioscience, Incorporation. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Forticell Bioscience, Incorporation Formerly known as Ortec International, Inc.. The Group's principal activity is to conduct research and development of tissue engineered skin regeneration product, for use in the treatment of chronic and acute wounds. The Group has developed a proprietary and patented technology known as OrCel, which is used to stimulate the repair and regeneration of human skin. OrCel is a two layered tissue engineered dressing that consists of human derived skin cells, both dermal and epidermal, supported within a porous collagen matrix. The composite matrix is seeded with keratinocytes for epidermal growth and fibroblasts for dermal growth. The Group also conducts a pivotal clinical trial for the use of OrCel in its cryopreserved form for the treatment of venous leg stasis and diabetic foot ulcers. The Group operates predominantly in the domestic market.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report